Lipocine Inc. Files 8-K
Ticker: LPCN · Form: 8-K · Filed: Feb 11, 2025 · CIK: 1535955
| Field | Detail |
|---|---|
| Company | Lipocine Inc. (LPCN) |
| Form Type | 8-K |
| Filed Date | Feb 11, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: LPCN
TL;DR
Lipocine filed a routine 8-K, no major news yet.
AI Summary
Lipocine Inc. filed an 8-K on February 11, 2025, reporting other events and financial statements. The filing does not contain specific details about new events, material agreements, or financial results within the provided text, but indicates a standard regulatory filing.
Why It Matters
This filing indicates Lipocine Inc. is meeting its regulatory reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits' without disclosing specific material events, suggesting no immediate new risks.
Key Players & Entities
- Lipocine Inc. (company) — Registrant
- February 11, 2025 (date) — Date of Report
- 675 Arapeen Drive, Suite 202 (address) — Principal executive offices
- Salt Lake City, Utah 84108 (address) — Principal executive offices
- 001-36357 (company_id) — Commission File Number
FAQ
What specific 'Other Events' are being reported by Lipocine Inc. in this 8-K filing?
The provided text for the 8-K filing indicates 'Other Events' as an item information, but does not specify the nature of these events.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on February 11, 2025.
What is the principal executive office address for Lipocine Inc.?
The principal executive office address for Lipocine Inc. is 675 Arapeen Drive, Suite 202, Salt Lake City, Utah 84108.
What is Lipocine Inc.'s Commission File Number?
Lipocine Inc.'s Commission File Number is 001-36357.
Does this filing include any new financial statements or exhibits?
Yes, the filing is categorized under 'Financial Statements and Exhibits', indicating that such documents are included, though their specific content is not detailed in the provided text.
Filing Stats: 411 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2025-02-11 09:00:16
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share LPCN The NASDAQ Stock Mar
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 46KB
- form8-k_001.jpg (GRAPHIC) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 64KB
- ex99-1_002.jpg (GRAPHIC) — 171KB
- ex99-1_003.jpg (GRAPHIC) — 108KB
- ex99-1_004.jpg (GRAPHIC) — 107KB
- ex99-1_005.jpg (GRAPHIC) — 58KB
- ex99-1_006.jpg (GRAPHIC) — 111KB
- ex99-1_007.jpg (GRAPHIC) — 107KB
- ex99-1_008.jpg (GRAPHIC) — 97KB
- ex99-1_009.jpg (GRAPHIC) — 109KB
- ex99-1_010.jpg (GRAPHIC) — 94KB
- ex99-1_011.jpg (GRAPHIC) — 67KB
- ex99-1_012.jpg (GRAPHIC) — 119KB
- ex99-1_013.jpg (GRAPHIC) — 87KB
- ex99-1_014.jpg (GRAPHIC) — 54KB
- ex99-1_015.jpg (GRAPHIC) — 138KB
- ex99-1_016.jpg (GRAPHIC) — 126KB
- ex99-1_017.jpg (GRAPHIC) — 135KB
- ex99-1_018.jpg (GRAPHIC) — 124KB
- ex99-1_019.jpg (GRAPHIC) — 73KB
- ex99-1_020.jpg (GRAPHIC) — 64KB
- ex99-1_021.jpg (GRAPHIC) — 86KB
- ex99-1_022.jpg (GRAPHIC) — 107KB
- ex99-1_023.jpg (GRAPHIC) — 90KB
- ex99-1_024.jpg (GRAPHIC) — 66KB
- ex99-1_025.jpg (GRAPHIC) — 149KB
- ex99-1_026.jpg (GRAPHIC) — 81KB
- ex99-1_027.jpg (GRAPHIC) — 113KB
- ex99-1_028.jpg (GRAPHIC) — 94KB
- ex99-1_029.jpg (GRAPHIC) — 41KB
- ex99-1_030.jpg (GRAPHIC) — 73KB
- ex99-1_031.jpg (GRAPHIC) — 95KB
- ex99-1_032.jpg (GRAPHIC) — 119KB
- ex99-1_033.jpg (GRAPHIC) — 36KB
- ex99-1_034.jpg (GRAPHIC) — 99KB
- ex99-1_035.jpg (GRAPHIC) — 140KB
- ex99-1_036.jpg (GRAPHIC) — 78KB
- ex99-1_037.jpg (GRAPHIC) — 113KB
- ex99-1_038.jpg (GRAPHIC) — 108KB
- ex99-1_039.jpg (GRAPHIC) — 87KB
- ex99-1_040.jpg (GRAPHIC) — 66KB
- ex99-1_041.jpg (GRAPHIC) — 100KB
- ex99-1_042.jpg (GRAPHIC) — 118KB
- ex99-1_043.jpg (GRAPHIC) — 64KB
- ex99-1_044.jpg (GRAPHIC) — 127KB
- ex99-1_045.jpg (GRAPHIC) — 100KB
- ex99-1_046.jpg (GRAPHIC) — 71KB
- ex99-1_047.jpg (GRAPHIC) — 82KB
- 0001493152-25-005809.txt ( ) — 6517KB
- lpcn-20250211.xsd (EX-101.SCH) — 3KB
- lpcn-20250211_lab.xml (EX-101.LAB) — 33KB
- lpcn-20250211_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIPOCINE INC. Date: February 11, 2025 By: /s/ Mahesh V. Patel Mahesh V. Patel President and Chief Executive Officer